Mahtab Samimi
Prof Mahtab Samimi is an expert in Dermatology at Centre Hospitalier Universitaire de Tours (France). As of October 2026, ScienceLeadR ranks Mahtab Samimi in the top 1% of experts worldwide for Carcinoma. Mahtab Samimi has authored 323 publications, the most recent in 2026, and is an investigator in 11 clinical trials, 5 of them ongoing. SLR score: 1,120 (community average: 125). How the SLR is computed.
LeadR Profile
Dermatology
Subspecialties: Oncology - Infectiology - Neurology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2008 - 2026
Number : 323
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Expert consensus on oral management in autoimmune bullous diseases, erythema multiforme and SJS/TEN. PMID 42482572 — oral manifestations, sexually transmitted diseases, hygiene, mouth mucosa, oral hygiene, skin diseases, epidermolysis bullosa, autoimmune diseases, erythema multiforme, therapeutics, mucous membrane, pemphigus, erythema | J Eur Acad Dermatol Venereol | 2026 | 0 |
| Lanreotide, a Somatostatin Analogue, in Advanced Merkel Cell Carcinoma: A Prospective Single-Arm Phase II Study. PMID 42791653 — cells, merkel cells, somatostatin, neoplasms, therapeutics, dermatology, carcinoma, merkel cell | Cancer Med | 2026 | 0 |
| Fibrosing Skin Disorder Associated With Zilucoplan. PMID 42616530 — skin, skin diseases | JAMA Dermatol | 2026 | 1 |
| Unexpected airway obstruction during intubation: a rare manifestation of Cowden syndrome. PMID 42190629 — sexually transmitted diseases, intubation, airway obstruction, hamartoma syndrome, multiple, dermatology | Ann Dermatol Venereol | 2026 | 0 |
| The impact of surgical excision modalities of Merkel cell carcinoma of the head and neck on recurrence, survival, and quality of life: A systematic review. PMID 42128698 — cells, quality of life, margins of excision, merkel cells, therapeutics, mohs surgery, carcinoma, merkel cell | Eur Ann Otorhinolaryngol Head Neck Dis | 2026 | 0 |
Clinical Studies 11
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
5 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Follow up of a French National Cohort of Patients With Cutaneous Squamous Cell Carcinoma Requiring Systemic Treatment NCT07606508 — skin, cells, carcinoma, squamous cell, neoadjuvant therapy, therapeutics, carcinoma, cutaneous squamous cell carcinoma | N/A | Recruiting | 2021 |
| VAC WARTS 2024-513671-40-00 — vaccines, warts, therapeutics | Phase 3 | Recruiting | 2022 |
| Upadacitinib in Adult Patients With Erosive Mucosal Lichen Planus and Lichen Planopilaris a Prospective Multicenter Randomized Placebo controlled Study NCT07492251 — skin, cells, safety, lichens, therapeutics, penis, lichen planus, wounds and injuries | Phase 2 | Recruiting | 2026 |
| SerUM Markers in MERkel Cell Carcinoma Patients a Longitudinal moniTorIng Study for optiMization of European Guidelines NCT04705389 — cells, merkel cells, blood, serum, antibodies, neoplasms, sampling studies, polyomavirus, biomarkers, diagnosis, antigens, viral, tumor, carcinoma, merkel cell, prognosis, merkel cell polyomavirus, carcinoma | N/A | Active not recruiting | 2022 |
| Randomized Double Blind Controlled Trial Comparing the Safety and Efficacy of Apremilast Versus Placebo in Severe Forms of Recurrent Aphthous Stomatitis NCT04227314 — stomatitis, aphthous, safety, tablets, stomatitis, therapeutics | Phase 3 | Recruiting | 2022 |
LeadR Networks
Main global connection map